NCT05535166 2026-02-12
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
St. Jude Children's Research Hospital
Phase 2 Recruiting
St. Jude Children's Research Hospital
Sapience Therapeutics
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
University Hospital, Bordeaux
National Cancer Institute (NCI)
Thomas Jefferson University
Thomas Jefferson University